🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

José A. G. Agúndez

Universidad de Extremadura

ORCID: 0000-0001-6895-9160
Pharmacology, Toxicology and PharmaceuticsMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.4Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

PharmVar GeneFocus: CYP2C19

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.1973
Top 6%
3.4DataRank
Top 6%142 citations

Michelle Whirl‐Carrillo, Andria L. Del Tredici, Katrin Sangkuhl, Larisa H. Cavallari, José A. G. Agúndez +10 more

Papers

Driven by 7 papers — median percentile 94. Top paper: “PharmVar GeneFocus: CYP2C19”.

PharmVar GeneFocus: CYP2C19

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.1973
Top 6%
3.4DataRank
Top 6%142 citations

Michelle Whirl‐Carrillo, Andria L. Del Tredici, Katrin Sangkuhl, Larisa H. Cavallari, José A. G. Agúndez +10 more

PharmVar GeneFocus: CYP2C9

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2333
N/A
2.1DataRank · unranked
77 citations

Karla Claudio‐Campos, Larisa H. Cavallari, José A. G. Agúndez, Michelle Whirl‐Carrillo, Jorgé Duconge +10 more

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3351
N/A
1.4DataRank · unranked
67 citations

Cameron D. Thomas, Craig R. Lee, Rachel Huddart, José A. G. Agúndez, Jordan Baye +13 more

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70071
N/A
0.269DataRank · unranked
5 citations

David W. Hein, Michael Asger Andersen, Arlene B. Chapman, Rhonda M. Cooper‐DeHoff, Zeruesenay Desta +14 more

Exome-wide rare variant analysis in familial essential tremor

Parkinsonism & Related Disorders(2020)10.1016/j.parkreldis.2020.11.021
N/A
0DataRank · unranked
15 citations

Gabrielle Houle, Sara Ortega‐Cubero, Sara Bandrés‐Ciga, Ignacio Álvarez, María Cárcel +28 more

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.1830
N/A
0DataRank · unranked
333 citations

Craig R. Lee, Li Gong, Kelly E. Caudle, Christine M. Formea, Andrea Gaedigk +4 more

PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3044
N/A
0DataRank · unranked
51 citations

Charity Nofziger, Bronwyn Ramey-Hartung, Reynold C. Ly, Chad Bousman, José A. G. Agúndez +12 more